- The trend backdrop is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
RO
EBS
Week ended 07 Aug 2026
Weekly Investor Report
Roche Holding AG · Healthcare · Drug Manufacturers - General
Latest close
372.6 CHF
3.8%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 9.4% above the Trend Line and sits at 95.2% of its 52-week range. The latest completed week returned 3.8%, after a 9.3% four-week move. The latest news-sentiment score is 63/100. Near-term considerations: price is close to its 52-week high.
Setup score
69
out of 100
Latest Close
372.6 CHF
7 Aug 2026
1W Return
3.8%
latest completed week
4W Return
9.3%
short-term follow-through
12W Return
12.3%
quarterly tape
Trend Breadth
67.3%
35 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- 2 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.8%
Latest completed week; four-week move 9.3%.
Indicator stack
40/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
63/100
6 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 9.4% above the Trend Line and sits at 95.2% of its 52-week range. The latest completed week returned 3.8%, after a 9.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7012-week average 0.58
12-week confirmation
Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.70Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 9.3% over four weeks, 12.3% over 12 weeks, and 49.3% over one year. The current trend has remained active for 1 consecutive weeks.
Performance by holding period
Active trend streak1 weeks
Active weeks in one year35
Trend breadth67.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.79Latest activity-pressure read.
Pressure change3876.3%Four-week change in activity pressure.
Leadership5.45Latest relative-leadership reading.
RS change1275.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment63/100
Weighted news tone is positive across 6 relevant articles.
5 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.6%Distance below the 52-week high.
13-week volatility2.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+6.0%Week of 24 Jul.
Worst week-7.6%Week of 6 Mar.
Latest week+3.8%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains10
Flat weeks0
Modest losses11
Sharp losses2
Recent vol2.6%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split29/22Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCH Healthcare
4-week rank5 / 40
Group average2.0%
Trend breadth52.5%
Trend52.5%active weekly trend signals
MD62.5%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryCH Drug Manufacturers - General
4-week rank1 / 6
Group average2.3%
Trend breadth83.3%
Trend83.3%active weekly trend signals
MD83.3%positive activity pressure
RS83.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape66/100
Trend, activity pressure, participation, and risk combine to a 66/100 tape read.
Indicator analysis45/100Latest 12-week confirmation: trend 4/12, activity pressure 4/12, relative leadership 8/12.
Activity pressure 0.70; 2 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment63/100Weighted news tone is positive across 6 relevant articles.
Did Stronger Guidance, Buybacks and New Oncology Tests Just Shift Labcorp Holdings' (LH) Investment Narrative? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 372.6 CHF | 3.8% | 340.6 CHF | 277.7 CHF | 0.79 | 5.45 | 95.9K | On |
| 31 Jul 2026 | 358.8 CHF | -0.3% | 339.4 CHF | 277.0 CHF | 0.58 | 3.33 | 105.0K | Off |
| 24 Jul 2026 | 360.0 CHF | 6.0% | 338.3 CHF | 276.3 CHF | 0.43 | 4.03 | 113.9K | Off |
| 17 Jul 2026 | 339.6 CHF | -0.4% | 337.2 CHF | 275.7 CHF | 0.23 | -1.75 | 95.9K | Off |
| 10 Jul 2026 | 341.0 CHF | -1.5% | 336.6 CHF | 275.2 CHF | -0.02 | -0.46 | 118.4K | Off |
| 3 Jul 2026 | 346.2 CHF | 1.2% | 335.8 CHF | 274.7 CHF | -0.22 | -0.13 | 12.7K | Off |
| 26 Jun 2026 | 342.0 CHF | 5.2% | 334.6 CHF | 274.1 CHF | -0.52 | 0.54 | 21.7K | Off |
| 19 Jun 2026 | 325.0 CHF | -2.7% | 333.5 CHF | 273.7 CHF | -0.59 | -1.56 | 56.7K | Off |
| 12 Jun 2026 | 334.0 CHF | 0.5% | 333.2 CHF | 273.3 CHF | -0.50 | 1.74 | 20.3K | Off |
| 5 Jun 2026 | 332.2 CHF | -1.3% | 331.8 CHF | 272.9 CHF | -0.59 | 3.74 | 24.2K | On |
| 29 May 2026 | 336.6 CHF | -0.8% | 329.7 CHF | 272.6 CHF | -0.59 | 4.11 | 297.0K | On |
| 22 May 2026 | 339.4 CHF | 2.3% | 327.3 CHF | 272.2 CHF | -0.76 | 5.52 | 171.2K | On |
| 15 May 2026 | 331.8 CHF | 2.7% | 325.1 CHF | 271.9 CHF | -0.87 | 5.63 | 102.0K | On |
| 8 May 2026 | 323.0 CHF | -1.1% | 323.6 CHF | 271.6 CHF | -0.84 | 4.07 | 120.6K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.